Human Anti-Human NTRK1 Therapeutic Antibody scFv Fragment (CRB0089)

This antibody recognises and binds to an epitope comprised in the TrkA amino acid sequence and inhibits NGF-mediated proliferative response in a dose dependent manner with an IC50 of approximately 43 nM. It is potentially useful in the treatment of diseases, including osteoarthritis pain and chronic pain.
Supplier Creative Biolabs
Product # TAB-170CQ-S(P)
Pricing Inquiry
Host Human
Target TrkA (Tyrosine kinase receptor of NGF)
Species Reactivity Human, Mouse
Type Human antibody
Applications Used for immunoassay techniques such as: Enzyme-linked Immunosorbent Assay; Flow Cytometry; Western Blot
Feedback